UBP
IHE icon

Union Bancaire Privee’s iShares US Pharmaceuticals ETF IHE Stock Holding History

Union Bancaire Privee’s Portfolio IHE Stock Details IHE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$57.9K Hold
660
– – ﹤0.01% 433
2026
Q1 		$48.5K Hold
660
– – ﹤0.01% 445
2025
Q4 		$48K Hold
660
– – ﹤0.01% 443
2025
Q3 		$39.5K Hold
660
– – ﹤0.01% 430
2025
Q2 		$36.9K Hold
660
– – ﹤0.01% 430
2025
Q1 		$41.8K Hold
660
– – ﹤0.01% 441
2024
Q4 		$41.6K Buy
+660
New +$45.4K ﹤0.01% 499

Other funds holding IHE

Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return
TD Asset Management
TD Asset Management Toronto, Ontario, Canada $115B AUM 41.58% 1-Year Est. Return
Mirae Asset Global Investments
Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 57.61% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return
IWS
Insight Wealth Strategies San Ramon, California $1.01B AUM 28.81% 1-Year Est. Return

Union Bancaire Privee's IHE Position: Q2 2026 in Review

Union Bancaire Privee held its iShares US Pharmaceuticals ETF (IHE) position steady in Q2 2026 at 660 shares worth $57.9K. The position accounts for ﹤0.01% of the portfolio, ranked #433.

Union Bancaire Privee first reported a position in IHE in Q4 2024 and has held it in 7 quarters since. 209 funds tracked by Wall St. Rank hold IHE as of Q2 2026.

  • Union Bancaire Privee held 660 shares of iShares US Pharmaceuticals ETF worth $57.9K as of Q2 2026.
  • Union Bancaire Privee left its iShares US Pharmaceuticals ETF share count unchanged in Q2 2026.
  • iShares US Pharmaceuticals ETF made up ﹤0.01% of Union Bancaire Privee's portfolio in Q2 2026, its #433 holding.
  • Union Bancaire Privee first reported a position in iShares US Pharmaceuticals ETF in Q4 2024 and has held it in 7 quarters since.
  • 209 funds tracked by Wall St. Rank held iShares US Pharmaceuticals ETF as of Q2 2026.

Based on Union Bancaire Privee's 13F filing for Q2 2026, filed 16 Jul 2026.